Spots Global Cancer Trial Database for New Formulation Study of Inupadenant (EOS100850) in Patients With Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: New Formulation Study of Inupadenant (EOS100850) in Patients With Cancer
Official Title: A Multicenter, Open-Label, Phase I Clinical Study to Assess the Safety, Tolerability, Pharmacokinetics and Food-Effect of Inupadenant New Formulation in Participants With Advanced Solid Tumors
Study ID: NCT05117177
Conditions
Interventions
Study Description
Brief Summary: A Multicenter, Open-Label, Phase I Clinical Study to assess the Safety, Tolerability, Pharmacokinetics and Food-Effect of Inupadenant New Formulation in Participants with Advanced Solid Tumors
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
GZA Ziekenhuizen, Antwerpen, , Belgium
Institut Jules Bordet, Brussels, , Belgium
Cliniques Universitaires St-Luc, Brussels, , Belgium
University Hospital Ghent, Ghent, , Belgium
Royal Marsden NHS Foundation Trust, London, , United Kingdom
Contact Details
Name: Jean-Pierre Machiels, MD, PhD
Affiliation: Cliniques Universitaires San Luc
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
